Featured Research

from universities, journals, and other organizations

Liver cancer screening highly beneficial for people with cirrhosis

Date:
May 5, 2014
Source:
UT Southwestern Medical Center
Summary:
Liver cancer survival rates could be improved if more people with cirrhosis are screened for tumors using inexpensive ultrasound scans and blood tests, according to a review. The meta-analysis of 47 studies involving more than 15,000 patients found that the three-year survival rate was much higher among patients who received liver cancer screening -- 51 percent for patients who were screened compared to 28 percent of unscreened patients.

Dr. Amit Singal, Assistant Professor of Internal Medicine and Clinical Sciences, and Medical Director of the Liver Tumor Clinic in the Harold C. Simmons Cancer Center
Credit: Image courtesy of UT Southwestern Medical Center

Liver cancer survival rates could be improved if more people with cirrhosis are screened for tumors using inexpensive ultrasound scans and blood tests, according to a review by doctors at UT Southwestern Medical Center.

Related Articles


The meta-analysis of 47 studies involving more than 15,000 patients found that the three-year survival rate was much higher among patients who received liver cancer screening -- 51 percent for patients who were screened compared to 28 percent of unscreened patients. The review also found that cirrhosis patients who were screened for liver cancer were more likely to receive curative treatment rather than palliative, or end-of-life, care.

"Curative therapies, such as surgery or a liver transplant, are only available if patients are found to have liver cancer at an early stage. Unfortunately, right now, only a minority of patients' cancers are found at an early stage," said Dr. Amit Singal, Assistant Professor of Internal Medicine and Clinical Sciences, and Medical Director of the Liver Tumor Clinic in the Harold C. Simmons Cancer Center, the only National Cancer Institute-designated cancer center in North Texas and one of just 66 NCI-designated cancer centers in the nation.

Rick Curiel, 60, of Forney, Texas, said liver cancer screening saved his life. Mr. Curiel, one of Dr. Singal's patients, had cirrhosis and a 2012 screening found tumors on his liver. The cancer was surgically treated at the Simmons Cancer Center, paving the way for him to have a life-saving liver transplant at UT Southwestern in 2013.

"Without the screening, they wouldn't have discovered it," said Mr. Curiel who was eventually able to return to work installing hardwood floors. "I am living proof that this works."

Liver cancer is the third leading cause of cancer-related deaths worldwide. People with cirrhosis are at a higher risk for liver cancer, with 3 to 5 percent of those with cirrhosis developing liver cancer every year. The rate at which the incidence of liver cancer is increasing is one of the fastest among all solid tumors in the U.S.

Dr. Singal's findings, published in the Public Library of Science Medical Journal, are particularly significant for Texas because the state has high rates of fatty liver disease and Hepatitis C, both of which are correlated with cirrhosis. Texas also has the second highest incidence of hepatocellular carcinoma, or HCC, the most common type of liver cancer in the U.S. Many cases of HCC can be caught early with screening.

"We have a simple test, an abdominal ultrasound which is painless and easy, but we found that less than 20 percent of at-risk people have the test done, largely due to providers failing to order it," Dr. Singal said. He said he hopes his study will encourage both patients and doctors to request the test.

Dr. Singal pointed out that liver cancer screening is not yet recommended by the United States Preventative Services Task Force, in part because a randomized study has not yet been done, which points to a conundrum in the field. When a randomized study was attempted in 2005, many patients opted out when they heard evidence that liver cancer screening could be so beneficial. None of the patients wanted to be the ones randomly chosen to not get the tests.

Dr. Singal hopes his findings will convince more cirrhosis patients and their doctors that screening is worthwhile.

"Just because we don't have a randomized trial doesn't mean there isn't a benefit. We're stuck in the middle ground where we've gone halfway. People are starting to believe liver cancer screening is helpful, but there's not enough evidence to prove a definite benefit," Dr. Singal said. "Part of our goal is providing evidence to both patients and physicians that liver cancer screening is beneficial."


Story Source:

The above story is based on materials provided by UT Southwestern Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Amit G. Singal, Anjana Pillai, Jasmin Tiro. Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis. PLoS Medicine, 2014; 11 (4): e1001624 DOI: 10.1371/journal.pmed.1001624

Cite This Page:

UT Southwestern Medical Center. "Liver cancer screening highly beneficial for people with cirrhosis." ScienceDaily. ScienceDaily, 5 May 2014. <www.sciencedaily.com/releases/2014/05/140505130201.htm>.
UT Southwestern Medical Center. (2014, May 5). Liver cancer screening highly beneficial for people with cirrhosis. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2014/05/140505130201.htm
UT Southwestern Medical Center. "Liver cancer screening highly beneficial for people with cirrhosis." ScienceDaily. www.sciencedaily.com/releases/2014/05/140505130201.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins